Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

키워드

참고문헌 (11)

1. Kim BK, "Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B : what else to keep in mind : Editorial on"Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients"", Clin Mol Hepatol, 30, pp.656~658 (2024)
2. Wu X, "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients", Clin Mol Hepatol, 29, pp.747~762 (2023)
3. Xu X, "Correspondence to editorial on"Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients"", Clin Mol Hepatol, 30, pp.994~996 (2024)
4. Lee JS, "External validation of the FSAC model using on-therapy changes in noninvasive fibrosis markers in patients with chronic hepatitis B : A multicenter study", Cancers(Basel), 14, pp.711~ (2022)
5. Nam H, "Prediction of hepatocellular carcinoma by on-therapy response of noninvasive fibrosis markers in chronic hepatitis B", Am J Gastroenterol, 116, pp.1657~1666 (2021)
6. Fan R, "Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures", J Hepatol, 79, pp.933~944 (2023)
7. Chun HS, "PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAgpositive chronic hepatitis B", J Hepatol, 80, pp.20~30 (2024)
8. Maino C, "Radiomics and liver : Where we are and where we are headed?", Eur J Radiol, 171, pp.111297~ (2024)
9. Hu P, "A combination model of radiomics features and clinical biomarkers as a nomogram to differentiate nonadvanced from advanced liver fibrosis : A retrospective study", Acad Radiol, 28(Suppl 1), pp.S45~S54 (2021)
10. Chen ZW, "A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease : a derivation and independent validation study", Hepatobiliary Surg Nutr, 11, pp.212~226 (2022)
11. Kim DH, "Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC", J Hepatol, 81, pp.461~470 (2024)

관련 논문AI추천